Skip to main content
ImmuneCited

Vitamin E 用于 Immune Aging (Immunosenescence)

B

Clinical trials in elderly populations demonstrate vitamin E supplementation at 200 IU/day may enhance delayed-type hypersensitivity (DTH) skin test response and antibody production. Recognized as one of the most effective single nutrients for modulating immune function in older adults.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002De\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

结论

Clinical trials in elderly populations demonstrate vitamin E supplementation at 200 IU/day may enhance delayed-type hypersensitivity (DTH) skin test response and antibody production. Recognized as one of the most effective single nutrients for modulating immune function in older adults.

Key Study Findings

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD 效果: None None

研究人群: Children with inflammatory bowel disease (review)

Observational Study n=2065
Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE …
Dose: None vs: None Outcome: CMV IgG association with oxidative stress markers 效果: None None

研究人群: Age-stratified general population (MARK-AGE RASIG cohort)

In Vitro
Anti-Hair Loss Potential of Perilla Seed Extracts: In Vitro Molecular Insights from Supercritical Fluid Extraction.
Dose: None vs: Untreated HFDPCs; finasteride, dutasteride, minoxidil Outcome: SRD5A1-3 and TGF-beta1 expression 效果: HFDPC proliferation 139.4+/-1.1% at 72h p<0.05

研究人群: Human hair follicle dermal papilla cells (in vitro)

Review
Nutrition, Immunosenescence, and Infectious Disease: An Overview of the Scientific Evidence on Micronutrients and on …
Dose: None vs: None Outcome: None 效果: None None

研究人群: Elderly with immunosenescence

Other
The impact of vitamin E and/or selenium dietary supplementation on growth parameters and expression levels …
Dose: 100 mg vs: control Outcome: None 效果: or 1 None

研究人群: None

Review n=26282 988 weeks
Inadequacy of Immune Health Nutrients: Intakes in US Adults, the 2005-2016 NHANES.
Dose: 45% vs: None Outcome: None 效果: None None

研究人群: None

Key Statistics

5

研究数量

600

受试者

Positive

B

等级

Referenced Papers

World journal of … 2015 62 次引用
Annual review of … 2014 9 次引用
Aging and disease 2012 209 次引用
Journal of comparative … 2010 17 次引用
The British journal … 2002 358 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
15 mg/day (22.4 IU)
immunesupportelderly:
200 IU/day

上限: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)

研究中使用的剂量

剂量 持续时间 效果 N
None -- Neutral --
None -- Negative 2065
None -- Positive --
None -- Mixed --
100 mg -- Positive --
45% 988 weeks Positive 26282
500 mg 12 weeks Mixed --
None -- Mixed --

最佳服用时间: With meals containing fat

Safety & Side Effects

已报告的副作用

  • Increased bleeding risk at high doses (>400 IU/day)
  • Nausea and gastrointestinal distress
  • Fatigue and muscle weakness at very high doses
  • Potential increased mortality risk at chronic high doses (meta-analysis finding, debated)

已知相互作用

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Statins (may reduce statin effectiveness)
  • Chemotherapy agents (may interfere with oxidative mechanisms)
  • Vitamin K (high-dose vitamin E may antagonize vitamin K)

可耐受最高摄入量: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Vitamin E help with Immune Aging (Immunosenescence)?
Based on 5 studies with 600 participants, there is moderate evidence from clinical studies that Vitamin E may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin E should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 15 mg/day (22.4 IU). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin E?
Reported side effects may include Increased bleeding risk at high doses (>400 IU/day), Nausea and gastrointestinal distress, Fatigue and muscle weakness at very high doses, Potential increased mortality risk at chronic high doses (meta-analysis finding, debated). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin E and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。